Clinical Trials Directory

Trials / Completed

CompletedNCT04799132

Association Between Body Mass Index and HFNC Therapy Success

Association Between Body Mass Index and High-flow Cannula Therapy Success in Patients With Severe Covid 19 Related Pneumonia. Retrospective Study.

Status
Completed
Phase
Study type
Observational
Enrollment
303 (actual)
Sponsor
Clínica del country · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients over 18 years of age who are admitted to the Intermediate Care Unit of the Clinica del Country and the Clinica la Colina, with symptoms suggestive of severe pneumonia secondary to COVID-19 infection and acute hypoxemic respiratory failure. The primary outcome will be to determine the relationship between body mass index and high-flow cannula therapy success defined as: No need for mechanical ventilation.

Detailed description

All adult patients over 18 years of age admitted to the intermediate care service of the participating center with suspected SARS-CoV-2 pneumonia will be considered as potential candidates for the study. The medical records of patients in our cohort who require high-flow cannula therapy and who met all the inclusion criteria and none of the exclusion criteria will be reviewed.All data will be processed and analyzed using the SPSS 26 software once the study is completed. study sample

Conditions

Timeline

Start date
2020-03-11
Primary completion
2021-03-01
Completion
2021-03-01
First posted
2021-03-16
Last updated
2021-03-16

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT04799132. Inclusion in this directory is not an endorsement.